Nader group challenges DES use as morning after pill
Consumer advocates led by Ralph Nader charge FDA with inaction on the DES based morning after pill use and criticize the University of Michigan for distributing DES to about 1000 students. They warn of long term cancer risks and insufficient patient information including family cancer history and lack of post treatment follow up.
MENTIONED IN THIS ARTICLE
Washington Associates
Ralph Nader
Food and Drug Administration
University of Michigan
Charles C. Edwards
Des
Edwards
Nader
The
Health Research Group
FDA
Journal of the American Medical Association
Anita Johnson
Sidney M. Wolfe
Michigan
Johnson and Wolfe
Ann Arbor
University Health Service
Also Mentioned on This Page
Nadar
Middletown
Wright
Roeder’s Pianos & Organs
Fair Oaks
N.Y
Tompkins